These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 17661172)

  • 1. Identification of rare complete BRCA1 gene deletion using a combination of SNP haplotype analysis, MLPA and array-CGH techniques.
    Konecny M; Zavodna K; Vranova V; Vizvaryova M; Weismanova E; Mlkva I; Kuglik P; Kausitz J; Bartosova Z
    Breast Cancer Res Treat; 2008 Jun; 109(3):581-3. PubMed ID: 17661172
    [No Abstract]   [Full Text] [Related]  

  • 2. Large BRCA1 and BRCA2 genomic rearrangements in Danish high risk breast-ovarian cancer families.
    Hansen Tv; Jønson L; Albrechtsen A; Andersen MK; Ejlertsen B; Nielsen FC
    Breast Cancer Res Treat; 2009 May; 115(2):315-23. PubMed ID: 18546071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Haplotype patterns in cancer-related genes with long-range linkage disequilibrium: no evidence of association with breast cancer or positive selection.
    Ribas G; Milne RL; Gonzalez-Neira A; Benítez J
    Eur J Hum Genet; 2008 Feb; 16(2):252-60. PubMed ID: 18000525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MLPA screening in the BRCA1 gene from 1,506 German hereditary breast cancer cases: novel deletions, frequent involvement of exon 17, and occurrence in single early-onset cases.
    Engert S; Wappenschmidt B; Betz B; Kast K; Kutsche M; Hellebrand H; Goecke TO; Kiechle M; Niederacher D; Schmutzler RK; Meindl A
    Hum Mutat; 2008 Jul; 29(7):948-58. PubMed ID: 18431737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BRCA1 and BRCA2 point mutations and large rearrangements in breast and ovarian cancer families in Northern Poland.
    Ratajska M; Brozek I; Senkus-Konefka E; Jassem J; Stepnowska M; Palomba G; Pisano M; Casula M; Palmieri G; Borg A; Limon J
    Oncol Rep; 2008 Jan; 19(1):263-8. PubMed ID: 18097605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA profiling of primary serous ovarian and fallopian tube carcinomas with array comparative genomic hybridization and multiplex ligation-dependent probe amplification.
    Nowee ME; Snijders AM; Rockx DA; de Wit RM; Kosma VM; Hämäläinen K; Schouten JP; Verheijen RH; van Diest PJ; Albertson DG; Dorsman JC
    J Pathol; 2007 Sep; 213(1):46-55. PubMed ID: 17668415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Haplotype-based analysis of genes associated with risk of adverse skin reactions after radiotherapy in breast cancer patients.
    Suga T; Ishikawa A; Kohda M; Otsuka Y; Yamada S; Yamamoto N; Shibamoto Y; Ogawa Y; Nomura K; Sho K; Omura M; Sekiguchi K; Kikuchi Y; Michikawa Y; Noda S; Sagara M; Ohashi J; Yoshinaga S; Mizoe J; Tsujii H; Iwakawa M; Imai T
    Int J Radiat Oncol Biol Phys; 2007 Nov; 69(3):685-93. PubMed ID: 17889263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluorescent resonance energy transfer (FRET) based detection of a multiplex ligation-dependent probe amplification assay (MLPA) product.
    Ozalp VC; Nygren AO; O'Sullivan CK
    Mol Biosyst; 2008 Sep; 4(9):950-4. PubMed ID: 18704233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Array-MLPA: comprehensive detection of deletions and duplications and its application to DMD patients.
    Zeng F; Ren ZR; Huang SZ; Kalf M; Mommersteeg M; Smit M; White S; Jin CL; Xu M; Zhou DW; Yan JB; Chen MJ; van Beuningen R; Huang SZ; den Dunnen J; Zeng YT; Wu Y
    Hum Mutat; 2008 Jan; 29(1):190-7. PubMed ID: 17854090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel deletion of BRCA1 gene that eliminates the ATG initiation codon without affecting the promoter region.
    Marino M; Rabacchi C; Simone ML; Medici V; Cortesi L; Calandra S
    Clin Chim Acta; 2009 May; 403(1-2):249-53. PubMed ID: 19393826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic variation in IGF-1 and breast cancer risk in Ashkenazi carriers and noncarriers of BRCA1/2 mutations.
    Khoury-Shakour S; Lejbkowicz F; Barnett-Griness O; Tamir A; Pinchev M; Rennert G
    Eur J Cancer Prev; 2009 Sep; 18(5):361-7. PubMed ID: 19543094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutation screening of the BRCA1 gene in sporadic breast cancer in southern Chinese populations.
    Haitian Z; Yunfei L; Jian Z; Jian L; Qinghua L; Fuqiang W
    Breast; 2008 Dec; 17(6):563-7. PubMed ID: 18835712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Relationship between mutation of BRCA1 and susceptibility to early onset of breast cancer].
    Meng J; Shi YR; Niu RF; Fu L
    Zhonghua Yi Xue Za Zhi; 2009 Jan; 89(2):79-82. PubMed ID: 19489266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amplifying small amounts of tumor DNA allows detection of DNA copy number abberations with array-CGH.
    Prestegarden L; Misra A; Ware ML; Yeh RF; Bjerkvig R; Feuerstein BG
    Biotechniques; 2008 Jun; 44(7):Piii-Pvi. PubMed ID: 18533897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hereditary protein S deficiency from a novel large deletion mutation of the PROS1 gene detected by multiplex ligation-dependent probe amplification (MLPA).
    Yoo JH; Kim HJ; Maeng HY; Kim YA; Sun YK; Song JW; Choi JR; Kim SH; Lee KA
    Thromb Res; 2009 Mar; 123(5):793-5. PubMed ID: 19168201
    [No Abstract]   [Full Text] [Related]  

  • 16. Plasmonics nanoprobes: detection of single-nucleotide polymorphisms in the breast cancer BRCA1 gene.
    Wabuyele MB; Yan F; Vo-Dinh T
    Anal Bioanal Chem; 2010 Sep; 398(2):729-36. PubMed ID: 20676618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-resolution genomic copy number profiling of glioblastoma multiforme by single nucleotide polymorphism DNA microarray.
    Yin D; Ogawa S; Kawamata N; Tunici P; Finocchiaro G; Eoli M; Ruckert C; Huynh T; Liu G; Kato M; Sanada M; Jauch A; Dugas M; Black KL; Koeffler HP
    Mol Cancer Res; 2009 May; 7(5):665-77. PubMed ID: 19435819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The p53 Arg72Pro and Ins16bp polymorphisms and their haplotypes are not associated with breast cancer risk in BRCA-mutation negative familial cases.
    De Vecchi G; Verderio P; Pizzamiglio S; Manoukian S; Bernard L; Pensotti V; Volorio S; Ravagnani F; Radice P; Peterlongo P
    Cancer Detect Prev; 2008; 32(2):140-3. PubMed ID: 18640791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular and in silico analysis of BRCA1 and BRCA2 variants.
    Tommasi S; Pilato B; Pinto R; Monaco A; Bruno M; Campana M; Digennaro M; Schittulli F; Lacalamita R; Paradiso A
    Mutat Res; 2008 Sep; 644(1-2):64-70. PubMed ID: 18694767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Multiplex ligation-dependent probe amplification and its application].
    Zhou DW; Ren ZR
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2009 Feb; 26(1):45-9. PubMed ID: 19199250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.